推荐产品
一般說明
Greiner CELLSTAR®微孔板通过先进的物理表面处理来提高细胞的粘附性。这些微孔板的特点是高清晰度和低自身荧光,确保了卓越的可视性和显微镜检查中的最小干扰。此外,这些微孔板使样品体积减少了50%,从而带来实验设置和样品节省方面的显著优势。
應用
Greiner CELLSTAR®微孔板已用于培养癌细胞、Zenbio 3T3-L1小鼠前脂肪细胞、骨髓源性巨噬细胞(BMDM)。它也被用于免疫荧光检测细胞活力。
特點和優勢
- 经过物理表面处理增强细胞粘附性
- 不含DNA酶、RNA酶和人类DNA
- 无菌、无细胞毒性、无热原,可叠放
- 板孔以字母数字形式编码,兼容自动化系统
- 高透明度微孔板,提供最佳的显微观察效果
- 样本材料交叉携带污染机会更低。
- 大小一致,符合美国国家标准研究院(ANSI)(ANSI/SBS 1-2004)要求。
- μClear®超薄底和连续批次编号
- 配有盖子,可在最少蒸发的情况下实现气体交换
法律資訊
μClear is a registered trademark of Greiner Bio-One GmbH
CELLSTAR is a registered trademark of Greiner Bio-One GmbH
Cancer letters, 526, 91-102 (2021-11-24)
Cancer cells display metabolic alterations to meet the bioenergetic demands for their high proliferation rates. Succinate is a central metabolite of the tricarboxylic acid (TCA) cycle, but was also shown to act as an oncometabolite and to specifically activate the
Frontiers in molecular biosciences, 9, 839428-839428 (2022-04-05)
Statins are successful drugs used to treat hypercholesterolemia, a primary cause of atherosclerosis. In this work, we investigated how hypercholesterolemia and pravastatin treatment impact macrophage and mitochondria functions, the key cell involved in atherogenesis. By comparing bone marrow-derived macrophages (BMDM)
PloS one, 13(3), e0194423-e0194423 (2018-03-20)
Autophagy is a cellular mechanism that can generate energy for cells or clear misfolded or aggregated proteins, and upregulating this process has been proposed as a therapeutic approach for neurodegenerative diseases. Here we describe a novel set of LC3B-II and
Toxicology, 461, 152900-152900 (2021-08-20)
The 3T3-L1 murine pre-adipocyte line is an established cell culture model for screening Metabolism Disrupting Chemicals (MDCs). Despite a need to accurately identify MDCs for further evaluation, relatively little research has been performed to comprehensively evaluate reproducibility across laboratories, assess
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门